BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haiser HJ, Turnbaugh PJ. Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 2013;69:21-31. [PMID: 22902524 DOI: 10.1016/j.phrs.2012.07.009] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Gemikonakli G, Mach J, Hilmer SN. Interactions Between the Aging Gut Microbiome and Common Geriatric Giants: Polypharmacy, Frailty, and Dementia. J Gerontol A Biol Sci Med Sci 2021;76:1019-28. [PMID: 32064521 DOI: 10.1093/gerona/glaa047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
2 Jia Q, Wang L, Zhang X, Ding Y, Li H, Yang Y, Zhang A, Li Y, Lv S, Zhang J. Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota. Pharmacol Res 2020;151:104552. [PMID: 31747557 DOI: 10.1016/j.phrs.2019.104552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
3 Bourlioux P. Actualité du microbiote intestinal. Annales Pharmaceutiques Françaises 2014;72:15-21. [DOI: 10.1016/j.pharma.2013.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
4 Cheng P, Shen P, Shan Y, Yang Y, Deng R, Chen W, Lu Y, Wei Z. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy. Front Cell Dev Biol 2021;9:626045. [PMID: 34568308 DOI: 10.3389/fcell.2021.626045] [Reference Citation Analysis]
5 Kuntz TM, Gilbert JA. Introducing the Microbiome into Precision Medicine. Trends in Pharmacological Sciences 2017;38:81-91. [DOI: 10.1016/j.tips.2016.10.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 13.5] [Reference Citation Analysis]
6 Velmurugan G. Gut microbiota in toxicological risk assessment of drugs and chemicals: The need of hour. Gut Microbes 2018;9:465-8. [PMID: 29509057 DOI: 10.1080/19490976.2018.1445955] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
7 Shah MS, DeSantis T, Yamal JM, Weir T, Ryan EP, Cope JL, Hollister EB. Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer. PLoS One 2018;13:e0207002. [PMID: 30412600 DOI: 10.1371/journal.pone.0207002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
8 Yip LY, Chan EC. Investigation of Host-Gut Microbiota Modulation of Therapeutic Outcome. Drug Metab Dispos 2015;43:1619-31. [PMID: 25979259 DOI: 10.1124/dmd.115.063750] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
9 Koontz JM, Dancy BCR, Horton CL, Stallings JD, DiVito VT, Lewis JA. The Role of the Human Microbiome in Chemical Toxicity. Int J Toxicol 2019;38:251-64. [PMID: 31220972 DOI: 10.1177/1091581819849833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
10 Raza MH, Gul K, Arshad A, Riaz N, Waheed U, Rauf A, Aldakheel F, Alduraywish S, Rehman MU, Abdullah M, Arshad M. Microbiota in cancer development and treatment. J Cancer Res Clin Oncol 2019;145:49-63. [PMID: 30542789 DOI: 10.1007/s00432-018-2816-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
11 Cheng SL, Li X, Lehmler HJ, Phillips B, Shen D, Cui JY. Gut Microbiota Modulates Interactions Between Polychlorinated Biphenyls and Bile Acid Homeostasis. Toxicol Sci 2018;166:269-87. [PMID: 30496569 DOI: 10.1093/toxsci/kfy208] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
12 Wang N, Sun T, Xu J. Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer. J Cancer 2021;12:4841-8. [PMID: 34234854 DOI: 10.7150/jca.58986] [Reference Citation Analysis]
13 Yoo DH, Kim IS, Van Le TK, Jung IH, Yoo HH, Kim DH. Gut microbiota-mediated drug interactions between lovastatin and antibiotics. Drug Metab Dispos 2014;42:1508-13. [PMID: 24947972 DOI: 10.1124/dmd.114.058354] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 10.9] [Reference Citation Analysis]
14 Zhang J, Zhang J, Wang R, Jia Z. Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes. Curr Drug Metab 2019;20:155-65. [PMID: 30338735 DOI: 10.2174/1389200219666181019145159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 van Baarlen P, Kleerebezem M, Wells JM. Omics approaches to study host-microbiota interactions. Curr Opin Microbiol 2013;16:270-7. [PMID: 23891019 DOI: 10.1016/j.mib.2013.07.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
16 Zidi O, Souai N, Raies H, Ben Ayed F, Mezlini A, Mezrioui S, Tranchida F, Sabatier JM, Mosbah A, Cherif A, Shintu L, Kouidhi S. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers. Molecules 2021;26:2266. [PMID: 33919750 DOI: 10.3390/molecules26082266] [Reference Citation Analysis]
17 Zaragoza-García O, Castro-Alarcón N, Pérez-Rubio G, Guzmán-Guzmán IP. DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy. Biomolecules 2020;10:E1479. [PMID: 33114390 DOI: 10.3390/biom10111479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Tralau T, Sowada J, Luch A. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology? Expert Opin Drug Metab Toxicol 2015;11:411-25. [PMID: 25476418 DOI: 10.1517/17425255.2015.990437] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
19 Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Inflammatory Bowel Disease: A Stressed "Gut/Feeling". Cells 2019;8:E659. [PMID: 31262067 DOI: 10.3390/cells8070659] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
20 Ervin SM, Ramanan SV, Bhatt AP. Relationship Between the Gut Microbiome and Systemic Chemotherapy. Dig Dis Sci 2020;65:874-84. [PMID: 32026181 DOI: 10.1007/s10620-020-06119-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
21 Thiele I, Clancy CM, Heinken A, Fleming RMT. Quantitative systems pharmacology and the personalized drug-microbiota-diet axis. Curr Opin Syst Biol 2017;4:43-52. [PMID: 32984662 DOI: 10.1016/j.coisb.2017.06.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
22 Ohadian Moghadam S, Momeni SA. Human microbiome and prostate cancer development: current insights into the prevention and treatment. Front Med 2021;15:11-32. [PMID: 32607819 DOI: 10.1007/s11684-019-0731-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tuteja S, Ferguson JF. Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med 2019;12:421-9. [PMID: 31462078 DOI: 10.1161/CIRCGEN.119.002314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
24 Scher JU, Nayak RR, Ubeda C, Turnbaugh PJ, Abramson SB. Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nat Rev Rheumatol 2020;16:282-92. [PMID: 32157196 DOI: 10.1038/s41584-020-0395-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 24.0] [Reference Citation Analysis]
25 Moore BD, Wiggins NL, Marsh KJ, Dearing MD, Foley WJ. Translating physiological signals to changes in feeding behaviour in mammals and the future effects of global climate change. Anim Prod Sci 2015;55:272. [DOI: 10.1071/an14487] [Cited by in Crossref: 19] [Article Influence: 3.2] [Reference Citation Analysis]
26 Alpert O, Begun L, Issac T, Solhkhah R. The brain-gut axis in gastrointestinal cancers. J Gastrointest Oncol 2021;12:S301-10. [PMID: 34422394 DOI: 10.21037/jgo-2019-gi-04] [Reference Citation Analysis]
27 Atashgahi S, Shetty SA, Smidt H, de Vos WM. Flux, Impact, and Fate of Halogenated Xenobiotic Compounds in the Gut. Front Physiol 2018;9:888. [PMID: 30042695 DOI: 10.3389/fphys.2018.00888] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
28 Tsunoda SM, Gonzales C, Jarmusch AK, Momper JD, Ma JD. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability. Clin Pharmacokinet 2021;60:971-84. [PMID: 33959897 DOI: 10.1007/s40262-021-01032-y] [Reference Citation Analysis]
29 Maurice CF, Turnbaugh PJ. Quantifying the metabolic activities of human-associated microbial communities across multiple ecological scales. FEMS Microbiol Rev 2013;37:830-48. [PMID: 23550823 DOI: 10.1111/1574-6976.12022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
30 Noh K, Kang YR, Nepal MR, Shakya R, Kang MJ, Kang W, Lee S, Jeong HG, Jeong TC. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs. Arch Pharm Res 2017;40:1345-55. [PMID: 29181640 DOI: 10.1007/s12272-017-0986-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
31 Ames NJ, Ranucci A, Moriyama B, Wallen GR. The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science. Nurs Res 2017;66:184-97. [PMID: 28252578 DOI: 10.1097/NNR.0000000000000212] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
32 Holmes M, Flaminio Z, Vardhan M, Xu F, Li X, Devinsky O, Saxena D. Cross talk between drug-resistant epilepsy and the gut microbiome. Epilepsia 2020;61:2619-28. [PMID: 33140419 DOI: 10.1111/epi.16744] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
33 Jourova L, Anzenbacher P, Matuskova Z, Vecera R, Strojil J, Kolar M, Nobilis M, Hermanova P, Hudcovic T, Kozakova H, Kverka M, Anzenbacherova E. Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome. Xenobiotica 2019;49:1296-302. [PMID: 30794062 DOI: 10.1080/00498254.2018.1558310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
34 Alagiakrishnan K, Halverson T. Microbial Therapeutics in Neurocognitive and Psychiatric Disorders. J Clin Med Res 2021;13:439-59. [PMID: 34691318 DOI: 10.14740/jocmr4575] [Reference Citation Analysis]
35 Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, Abadia-Molina F. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases. Nutrients 2020;12:E605. [PMID: 32110880 DOI: 10.3390/nu12030605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 33.0] [Reference Citation Analysis]
36 Kumar M, Singh P, Murugesan S, Vetizou M, McCulloch J, Badger JH, Trinchieri G, Al Khodor S. Microbiome as an Immunological Modifier. Methods Mol Biol 2020;2055:595-638. [PMID: 31502171 DOI: 10.1007/978-1-4939-9773-2_27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
37 Zou L, Spanogiannopoulos P, Pieper LM, Chien HC, Cai W, Khuri N, Pottel J, Vora B, Ni Z, Tsakalozou E, Zhang W, Shoichet BK, Giacomini KM, Turnbaugh PJ. Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. Proc Natl Acad Sci U S A 2020;117:16009-18. [PMID: 32571913 DOI: 10.1073/pnas.1920483117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
38 Gomez A, Petrzelkova KJ, Burns MB, Yeoman CJ, Amato KR, Vlckova K, Modry D, Todd A, Jost Robinson CA, Remis MJ, Torralba MG, Morton E, Umaña JD, Carbonero F, Gaskins HR, Nelson KE, Wilson BA, Stumpf RM, White BA, Leigh SR, Blekhman R. Gut Microbiome of Coexisting BaAka Pygmies and Bantu Reflects Gradients of Traditional Subsistence Patterns. Cell Rep 2016;14:2142-53. [PMID: 26923597 DOI: 10.1016/j.celrep.2016.02.013] [Cited by in Crossref: 126] [Cited by in F6Publishing: 112] [Article Influence: 25.2] [Reference Citation Analysis]
39 Sharma A, Buschmann MM, Gilbert JA. Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response? Clin Pharmacol Ther 2019;106:317-28. [PMID: 30937887 DOI: 10.1002/cpt.1437] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
40 Levi Mortera S, Soggiu A, Vernocchi P, Del Chierico F, Piras C, Carsetti R, Marzano V, Britti D, Urbani A, Roncada P, Putignani L. Metaproteomic investigation to assess gut microbiota shaping in newborn mice: A combined taxonomic, functional and quantitative approach. J Proteomics 2019;203:103378. [PMID: 31102759 DOI: 10.1016/j.jprot.2019.103378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Dempsey JL, Little M, Cui JY. Gut microbiome: An intermediary to neurotoxicity. Neurotoxicology 2019;75:41-69. [PMID: 31454513 DOI: 10.1016/j.neuro.2019.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
42 Zhang R, Gao X, Bai H, Ning K. Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare. Front Pharmacol 2020;11:538. [PMID: 32390855 DOI: 10.3389/fphar.2020.00538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
43 Thomas V, Clark J, Doré J. Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies. Future Microbiol 2015;10:1485-504. [PMID: 26347019 DOI: 10.2217/fmb.15.87] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
44 Sowada J, Schmalenberger A, Ebner I, Luch A, Tralau T. Degradation of benzo[ a ]pyrene by bacterial isolates from human skin. FEMS Microbiol Ecol 2014;88:129-39. [DOI: 10.1111/1574-6941.12276] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
45 Heinken A, Thiele I. Systems biology of host-microbe metabolomics. Wiley Interdiscip Rev Syst Biol Med 2015;7:195-219. [PMID: 25929487 DOI: 10.1002/wsbm.1301] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
46 Moussa HA, Wasfi R, Abdeltawab NF, Megahed SA. High Counts and Anthracene Degradation Ability of Streptococcus mutans and Veillonella parvula Isolated From the Oral Cavity of Cigarette Smokers and Non-smokers. Front Microbiol 2021;12:661509. [PMID: 34262538 DOI: 10.3389/fmicb.2021.661509] [Reference Citation Analysis]
47 He Y, Chevillet JR, Liu G, Kim TK, Wang K. The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs. Br J Pharmacol 2015;172:2733-47. [PMID: 25296724 DOI: 10.1111/bph.12968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
48 Evariste L, Flahaut E, Baratange C, Barret M, Mouchet F, Pinelli E, Galibert AM, Soula B, Gauthier L. Ecotoxicological assessment of commercial boron nitride nanotubes toward Xenopus laevis tadpoles and host-associated gut microbiota. Nanotoxicology 2021;15:35-51. [PMID: 33171057 DOI: 10.1080/17435390.2020.1839137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Saad R, Rizkallah MR, Aziz RK. Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Gut Pathog 2012;4:16. [PMID: 23194438 DOI: 10.1186/1757-4749-4-16] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 9.7] [Reference Citation Analysis]
50 Wilkinson EM, Ilhan ZE, Herbst-kralovetz MM. Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas 2018;112:53-63. [DOI: 10.1016/j.maturitas.2018.03.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
51 Hahn AS, Altman T, Konwar KM, Hanson NW, Kim D, Relman DA, Dill DL, Hallam SJ. A geographically-diverse collection of 418 human gut microbiome pathway genome databases. Sci Data 2017;4:170035. [PMID: 28398290 DOI: 10.1038/sdata.2017.35] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
52 Saeed A, Eshrat FF, Umar S, Saeed A. The Duplex Interaction of Microbiome with Chemoradiation and Immunotherapy: Potential Implications for Colorectal Cancer. Curr Colorectal Cancer Rep 2019;15:98-104. [PMID: 31680787 DOI: 10.1007/s11888-019-00435-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Beebe K, Sampey B, Watkins SM, Milburn M, Eckhart AD. Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. Clin Transl Sci 2014;7:74-81. [PMID: 24422665 DOI: 10.1111/cts.12131] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
54 Abbasian F, Lockington R, Megharaj M, Naidu R. The integration of sequencing and bioinformatics in metagenomics. Rev Environ Sci Biotechnol 2015;14:357-83. [DOI: 10.1007/s11157-015-9365-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
55 Park GS, Park MH, Shin W, Zhao C, Sheikh S, Oh SJ, Kim HJ. Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro. Stem Cell Rev Rep 2017;13:321-34. [PMID: 28488235 DOI: 10.1007/s12015-017-9739-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 13.7] [Reference Citation Analysis]
56 Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14:273-287. [PMID: 26972811 DOI: 10.1038/nrmicro.2016.17] [Cited by in Crossref: 341] [Cited by in F6Publishing: 298] [Article Influence: 68.2] [Reference Citation Analysis]
57 ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 2014;18:402-14. [PMID: 24785449 DOI: 10.1089/omi.2014.0018] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
58 Börnigen D, Morgan XC, Franzosa EA, Ren B, Xavier RJ, Garrett WS, Huttenhower C. Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med 2013;5:65. [PMID: 23906180 DOI: 10.1186/gm469] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
59 Li H, He J, Jia W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 2016;12:31-40. [PMID: 26569070 DOI: 10.1517/17425255.2016.1121234] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 16.3] [Reference Citation Analysis]
60 Patterson AD, Turnbaugh PJ. Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology. Cell Metab 2014;20:761-8. [PMID: 25156450 DOI: 10.1016/j.cmet.2014.07.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
61 Tao J, Zhao M, Ling Y, Jiang S, Qiu W. UPLC-Q-TOF/MS-based Metabolic Profiles of Bioactive Components in Rehmannia glutinosa and Cornus officinalis Herb Pair by Rat Intestinal Bacteria. Chinese Herbal Medicines 2017;9:147-52. [DOI: 10.1016/s1674-6384(17)60088-1] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
62 Sharma AK, Jaiswal SK, Chaudhary N, Sharma VK. A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Sci Rep 2017;7:9751. [PMID: 28852076 DOI: 10.1038/s41598-017-10203-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
63 Pirsaheb M, Hossini H, Makhdoumi P. Review of microplastic occurrence and toxicological effects in marine environment: Experimental evidence of inflammation. Process Safety and Environmental Protection 2020;142:1-14. [DOI: 10.1016/j.psep.2020.05.050] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 30.0] [Reference Citation Analysis]
64 Gately S. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients. In: Von Hoff DD, Han H, editors. Precision Medicine in Cancer Therapy. Cham: Springer International Publishing; 2019. pp. 253-64. [DOI: 10.1007/978-3-030-16391-4_10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
65 Zheng N, Gu Y, Hong Y, Sheng L, Chen L, Zhang F, Hou J, Zhang W, Zhang Z, Jia W, Li H. Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid. J Pharm Anal 2020;10:560-70. [PMID: 33425450 DOI: 10.1016/j.jpha.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Hyland NP, Cryan JF. When pharmacology meets the microbiome: new targets for therapeutics? Br J Pharmacol 2018;175:4401-3. [PMID: 30478976 DOI: 10.1111/bph.14502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Claus SP, Guillou H, Ellero-Simatos S. The gut microbiota: a major player in the toxicity of environmental pollutants? NPJ Biofilms Microbiomes. 2016;2:16003. [PMID: 28721242 DOI: 10.1038/npjbiofilms.2016.3] [Cited by in Crossref: 246] [Cited by in F6Publishing: 216] [Article Influence: 49.2] [Reference Citation Analysis]
68 Ursell LK, Haiser HJ, Van Treuren W, Garg N, Reddivari L, Vanamala J, Dorrestein PC, Turnbaugh PJ, Knight R. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 2014;146:1470-6. [PMID: 24631493 DOI: 10.1053/j.gastro.2014.03.001] [Cited by in Crossref: 133] [Cited by in F6Publishing: 117] [Article Influence: 19.0] [Reference Citation Analysis]
69 Yeruva T, Lee CH. Regulation of Vaginal Microbiome by Nitric Oxide. Curr Pharm Biotechnol 2019;20:17-31. [PMID: 30727888 DOI: 10.2174/1389201020666190207092850] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Haiser HJ, Seim KL, Balskus EP, Turnbaugh PJ. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 2014;5:233-8. [PMID: 24637603 DOI: 10.4161/gmic.27915] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 12.1] [Reference Citation Analysis]
71 Dong J, Gao HL, Wang WQ, Yu XJ, Liu L. Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188484. [PMID: 33246025 DOI: 10.1016/j.bbcan.2020.188484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Aziz RK, Hegazy SM, Yasser R, Rizkallah MR, ElRakaiby MT. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions. Expert Opin Drug Metab Toxicol 2018;14:1043-55. [PMID: 30269615 DOI: 10.1080/17425255.2018.1530216] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
73 Parida S, Sharma D. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer. Biochim Biophys Acta Rev Cancer 2019;1871:392-405. [PMID: 30981803 DOI: 10.1016/j.bbcan.2019.04.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
74 Zhang J, Zhang J, Wang R. Gut microbiota modulates drug pharmacokinetics. Drug Metab Rev 2018;50:357-68. [PMID: 30227749 DOI: 10.1080/03602532.2018.1497647] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
75 Wang Z, Xu Z, Li X. Biodegradation of methamphetamine and ketamine in aquatic ecosystem and associated shift in bacterial community. Journal of Hazardous Materials 2018;359:356-64. [DOI: 10.1016/j.jhazmat.2018.07.039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
76 Zhan J, Liang Y, Liu D, Ma X, Li P, Liu C, Liu X, Wang P, Zhou Z. Antibiotics may increase triazine herbicide exposure risk via disturbing gut microbiota. Microbiome 2018;6:224. [PMID: 30545405 DOI: 10.1186/s40168-018-0602-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
77 Walsh J, Griffin BT, Clarke G, Hyland NP. Drug-gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol 2018;175:4415-29. [PMID: 29782640 DOI: 10.1111/bph.14366] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
78 Ghosh S, Pramanik S. Structural diversity, functional aspects and future therapeutic applications of human gut microbiome. Arch Microbiol 2021;203:5281-308. [PMID: 34405262 DOI: 10.1007/s00203-021-02516-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
79 Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015;66:343-359. [PMID: 25587655 DOI: 10.1146/annurev-med-060513-093205] [Cited by in Crossref: 198] [Cited by in F6Publishing: 180] [Article Influence: 33.0] [Reference Citation Analysis]
80 Lee H, Ko G. Antiviral effect of vitamin A on norovirus infection via modulation of the gut microbiome. Sci Rep 2016;6:25835. [PMID: 27180604 DOI: 10.1038/srep25835] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
81 Mehmood K, Moin A, Hussain T, Rizvi SMD, Gowda DV, Shakil S, Kamal MA. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management? Folia Microbiol (Praha) 2021;66:897-916. [PMID: 34699042 DOI: 10.1007/s12223-021-00926-5] [Reference Citation Analysis]
82 Khojasteh SC, Rietjens IMCM, Dalvie D, Miller G. Biotransformation and bioactivation reactions - 2016 literature highlights. Drug Metab Rev 2017;49:285-317. [PMID: 28468514 DOI: 10.1080/03602532.2017.1326498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
83 Evariste L, Barret M, Mottier A, Mouchet F, Gauthier L, Pinelli E. Gut microbiota of aquatic organisms: A key endpoint for ecotoxicological studies. Environmental Pollution 2019;248:989-99. [DOI: 10.1016/j.envpol.2019.02.101] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 28.0] [Reference Citation Analysis]
84 Velmurugan G, Ramprasath T, Swaminathan K, Mithieux G, Rajendhran J, Dhivakar M, Parthasarathy A, Babu DD, Thumburaj LJ, Freddy AJ, Dinakaran V, Puhari SS, Rekha B, Christy YJ, Anusha S, Divya G, Suganya K, Meganathan B, Kalyanaraman N, Vasudevan V, Kamaraj R, Karthik M, Jeyakumar B, Abhishek A, Paul E, Pushpanathan M, Rajmohan RK, Velayutham K, Lyon AR, Ramasamy S. Gut microbial degradation of organophosphate insecticides-induces glucose intolerance via gluconeogenesis. Genome Biol 2017;18:8. [PMID: 28115022 DOI: 10.1186/s13059-016-1134-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 14.0] [Reference Citation Analysis]
85 Castillo-Álvarez F, Marzo-Sola ME. Role of intestinal microbiota in the development of multiple sclerosis. Neurologia 2017;32:175-84. [PMID: 26383059 DOI: 10.1016/j.nrl.2015.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
86 Amirian ES, Petrosino JF, Ajami NJ, Liu Y, Mims MP, Scheurer ME. Potential role of gastrointestinal microbiota composition in prostate cancer risk. Infect Agent Cancer 2013;8:42. [PMID: 24180596 DOI: 10.1186/1750-9378-8-42] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
87 Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, Oltman CL, Azcarate-Peril MA, Kirby JR, Calarge CA. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry 2015;5:e652. [PMID: 26440540 DOI: 10.1038/tp.2015.135] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 15.0] [Reference Citation Analysis]
88 Castillo-álvarez F, Marzo-sola M. Role of intestinal microbiota in the development of multiple sclerosis. Neurología (English Edition) 2017;32:175-84. [DOI: 10.1016/j.nrleng.2015.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 2014;124:4173-81. [PMID: 25105361 DOI: 10.1172/JCI72335] [Cited by in Crossref: 155] [Cited by in F6Publishing: 85] [Article Influence: 22.1] [Reference Citation Analysis]
90 Ribeiro LF, Lopes EM, Kishi LT, Ribeiro LFC, Menegueti MG, Gaspar GG, Silva-Rocha R, Guazzaroni ME. Microbial Community Profiling in Intensive Care Units Expose Limitations in Current Sanitary Standards. Front Public Health 2019;7:240. [PMID: 31555629 DOI: 10.3389/fpubh.2019.00240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
91 Klünemann M, Schmid M, Patil KR. Computational tools for modeling xenometabolism of the human gut microbiota. Trends Biotechnol. 2014;32:157-165. [PMID: 24529988 DOI: 10.1016/j.tibtech.2014.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
92 Kang MJ, Kim HG, Kim JS, Oh DG, Um YJ, Seo CS, Han JW, Cho HJ, Kim GH, Jeong TC, Jeong HG. The effect of gut microbiota on drug metabolism. Expert Opin Drug Metab Toxicol 2013;9:1295-308. [PMID: 24033282 DOI: 10.1517/17425255.2013.807798] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 9.5] [Reference Citation Analysis]
93 Ma S, Shen L, Chen M, Lin X, Wang Q, Du R, Feng Y. The study of metabonomics combined with diversity of intestinal flora in LDP intervention in kidney-yin deficiency hyperthyroid rats. RSC Adv 2015;5:57975-83. [DOI: 10.1039/c5ra10134d] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
94 Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep 2015;5:14554. [PMID: 26416623 DOI: 10.1038/srep14554] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 14.5] [Reference Citation Analysis]
95 Zahran SA, Ali-Tammam M, Hashem AM, Aziz RK, Ali AE. Azoreductase activity of dye-decolorizing bacteria isolated from the human gut microbiota. Sci Rep 2019;9:5508. [PMID: 30940826 DOI: 10.1038/s41598-019-41894-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
96 Zahran SA, Ali-Tammam M, Ali AE, Aziz RK. Compositional variation of the human fecal microbiome in relation to azo-reducing activity: a pilot study. Gut Pathog 2021;13:58. [PMID: 34625106 DOI: 10.1186/s13099-021-00454-0] [Reference Citation Analysis]
97 Wang Q, Spenkelink B, Boonpawa R, Rietjens IMCM, Beekmann K. Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation. Mol Nutr Food Res 2020;64:e1900912. [PMID: 32027771 DOI: 10.1002/mnfr.201900912] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
98 Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17:271-285. [PMID: 28303904 DOI: 10.1038/nrc.2017.13] [Cited by in Crossref: 370] [Cited by in F6Publishing: 349] [Article Influence: 92.5] [Reference Citation Analysis]